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General practice records are a unique source of infor-
mation which can help us as medical researchers to
improve our understanding of disease, develop potential
new treatments and improve the care of our patients.
The use of general practice electronic records is
increasing and until recently there was little consensus
on how such records could be accessed and used for
research. The recently published document by the
Wellcome Trust1 provides guidelines for best practice
in the use of electronic patient records for research and
is the result of a national consensus meeting held in
2008 with general practitioners (GPs), researchers and
patient groups. This report is very timely and proposes
three overarching principles as a basis for best practice.
One of these key principles is that personal informa-
tion held within patient records may be both sensitive
and private so security and conﬁdentiality must be
safeguarded at all times if the general public, patients
and healthcare professionals are to have conﬁdence in
the processes used by researchers to access the records.
Patient conﬁdentiality can be maintained at a tech-
nical level by the use of the best available electronic
technologies which ensure security and conﬁdentiality.
The introduction of safe havens and honest brokers
provide further mechanisms for maintaining the con-
ﬁdentiality of data. Safe havens are deﬁned as desig-
nated physical or electronic areas that provide the
most appropriate level of security for the use of data.
Researchers working in safe havens should be ‘bound
by a strict code, preventing disclosure of any personally
identifying information’ (p.14). The UK Government
in its response to the Data Sharing Review2 has accepted
a recommendation for the development of safe havens
to minimise the risk of individuals being identiﬁed
and has committed itself to developing a system to
ensure that only ‘accredited researchers’ work within
safe havens.
An honest broker is a trusted custodian of data,
with the dual role of ‘ensuring patient data conﬁden-
tiality and security and ensuring scientiﬁc integrity of
data’ (p.14), i.e. he/she is responsible for ensuring that
the coding and anonymisation processes are correctly
implemented and for carrying out data quality checks
that, for reasons of conﬁdentiality, it is not possible for
researchers to do themselves.
The consensus document distinguishes between
three levels of identiﬁable information: the ﬁrst level
is anonymised (other terms which may be used are:
irreversibly de-identiﬁed; unlinked anonymised in-
formation and unidentiﬁable). At this level, it is not
possible to identify an individual because, although
data are provided at an individual level, there is noway
of establishing a link with the original, identiﬁable
clinical record. Data at this level do not include iden-
tiﬁers such as name, address, full postcode, full date of
birth or NHS number. (These are so-called strong
identiﬁers.)
The second level of identiﬁable information is
coded data where it is not possible to directly identify
an individual but where a key is available which enables
the identity of the patient to be linked to the data by
the person who holds the key. This coded identiﬁer
should be globally unique and the key needs to be held
under strict conditions. Alternatively, the data may
become identiﬁable when used together with other
data sources. The likelihood of such identiﬁcation is
increased when data relates to individuals with rare
illnesses or exposures, or to small or unusual popu-
lations. (Other terms used for coded data include:
pseudonymous; key-coded; reversibly de-identiﬁed;
linked anonymised; masked and encrypted.)
The third level of identiﬁable information is, of
course, any personal data that directly identiﬁes
individuals. (The other terms which may be used at
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this data level include: identiﬁed; personal and nomi-
native.) In these circumstances, individual informed
consent is normally required before identiﬁable data
can be used for research. However, in England special
permission may need to be obtained where it is not
possible or practical to seek consent, in which case the
Ethics and Conﬁdentiality Committee of the National
Information Governance Board for Health and Social
Care would consider such applications.3
In addition to these technical safeguards, patient con-
ﬁdentiality also needs to be controlled at the researcher
level by ensuring that only accredited, approved re-
searchers have access to identiﬁable patient infor-
mation. The report recommends that researchers are
placed under the same duty of conﬁdentiality as health
professionals and that appropriate and substantive,
possibly criminal, sanctions should be applied for any
breaches of conﬁdentiality.
There are considerable implications for us as re-
searchers arising from this guidance. It is clear that
academic researchers need to work closely with GPs
and healthcare professionals who retain ultimate re-
sponsibility for ensuring that data are accessed appro-
priately. TheWellcome Best Practice Guidance provides
a framework for a greatermutual understanding of the
diﬀerent roles and responsibilities of clinicians and
researchers. However, although the public are generally
supportive of research and two-thirds of people are
likely or certain to allow personal health information
to be used for research, there is little public under-
standing of what this actually means in practice. A
national awareness raising programme is, therefore,
recommended by the report to highlight the import-
ance of using patient records for research, describing
the diﬀerence between identiﬁable and non-identiﬁ-
able data and explaining the safeguards which are in
place to protect privacy. Some controversy remains,
however – particularly in the areas of ‘opting in/opting
out’ and ‘consent for consent’. The report recom-
mends that patients should be informed on a number
of occasions, such as when registering with a general
practice, that they can if they wish opt out of the use of
their identiﬁable information in research. Other op-
portunities for informing patients about opt-out could
include prominently displayed notices inwaiting rooms,
and there is a need to develop a process whereby
dissent to research can be recorded within individual
medical records. Informedconsent is, of course, required
for participation in individual research projects when
identiﬁable data are to be used – a detailed account for
best practice in these circumstances is provided by the
Wellcome report.
When patients are to be invited to take part in
research, greater clarity is also needed about the
mechanism for contacting potential study recruits.
GPs are sometimes required to contact patients in the
ﬁrst instance to ask whether they are happy to be
contacted at a later time with information about a
study. Only after this initial contact can researchers
contact patients to invite them to participate in the
study. The Data Sharing Review report4 described this
need for consent to gain consent as a ‘problem that
requires a solution’ (p.27). It is clear that response
rates may be higher when patients are invited by their
GPs to participate in a study: possible reasons for this
include the high levels of trust in GPs consistently
expressed by the public and the high status given to a
GP’s endorsement of a particular study. However, GP
involvement in contacting patients may require sig-
niﬁcant time and resources which can be a substantial
barrier to conducting research.
It is clear that the Wellcome report is a big step in
the right direction for researchers wishing to use data
from general practice patient records for research and
the report demonstrates clearly that there is a growing
consensus on best practice between GPs, patients, the
public and researchers, although a number of outstand-
ing issues remain. The full report can be accessed on
www.wellcome.ac.uk/gprecords.
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